Table 1.
Sociodemographic characteristics and ART intake profile of adult patients on dolutegravir-based regimen at CDCRC AEFUTHA
| Variable | Frequency N=515 n (%) |
| Age in years | |
| < 40 | 140 (27.2) |
| 40 - 49 | 207 (40.2) |
| 50 - 59 | 116 (22.5) |
| ≥ 60 | 52 (10.1) |
| Mean age | 45.5±10.8ms |
| Sex | |
| Female | 351 (68.2) |
| Male | 164 (31.8) |
| ART history at start of DTG | |
| ART-experienced | 377 (73.2) |
| ART-naive | 138 (26.8) |
| Duration of intake of any ART (in years) mi | |
| Patients transitioned to DTG (N = 377) | 10.1 (3.4)mi |
| Patients initiated on DTG (N = 138) | 1.5 (1.5)mi |
| Overall (N = 515) | 9.0 (8.7)mi |
| Duration of intake of DTG-based ART (in years) | |
| Patients transitioned to DTG (N = 377) | 2.8 (0.4)mi |
| Patients initiated on DTG (N = 138) | 1.5 (1.5)mi |
| Overall (N = 515) | 2.7 (0.8)mi |
| Number of clinic attendance since the commencement of DTG | |
| < 11 | 131 (25.4) |
| 11 - 15 | 323 (62.7) |
| > 15 | 61 (11.8) |
| Mean attendance | 12.2±3.1ms |
ms = mean ± standard deviation; mi = median (interquartile range)